跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LINAGLIPTINA SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LINAGLIPTINA SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LINAGLIPTINA SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2025
Approval ID
e31ad5a6744805e4
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
e31ad5a6744805e4
Drug Cima Aemps Name
LINAGLIPTINA SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90183
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2025-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
LINAGLIPTINA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2025
Approval ID
e31ad5a6744805e4
Type
Standard
Back to CIMA-AEMPS Approvals